| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human APRIL/TNFSF13 (HEK293-expressed), CF |
|---|
| Description | Purity >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 26 kDa, reducing conditions. MW (theoretical): 21.7 kDa. The Recombinant Human APRIL/TNFSF13 (HEK293-expressed) from R&D Systems is derived from HEK293. The Recombinant Human APRIL/TNFSF13 (HEK293-expressed) has been validated for the following applications: Bioactivity. |
|---|
| Size | 10 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | A proliferation-inducing ligand, APRILFLJ57090, CD256, CD256 antigen, TALL2, TALL-2, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TNFSF13, TRDL1, TRDL-1, tumor necrosis factor (ligand) superfamily, member 13, tumor necrosis factor ligand superfamily member 13, tumor necrosis factor-like protein ZTNF2, tumor necrosis factor-related death ligand-1, ZTNF2 |
|---|
| Gene, Accession, CAS # | TNFSF13, Gene ID: 8741, Accession: O75888 |
|---|
| Catalog # | 5860-AP-010/CF |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human APRIL/TNFSF13 (HEK293-expressed), CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 23588715, 24444792, 24550522, 25950010, 26139429, 28835384 |
|---|
| 产品资料 |
|
|